Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in Forte Biosciences, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +12 vs. Q4 2025
- Shares held
- 13.5M
- +2.58M (+23.6%) vs. Q4 2025
- Total value
- $350.2M
- +$51.6M (+17.3%) vs. Q4 2025
- New holders
- 19
- 21 more added
- Sold out
- 7
- 20 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,765,516 | $45.7M | 0.07% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 1,273,965 | $33.0M | 0.14% | −187,006−12.8% | Reduced |
| OrbiMed Advisors LLC | 1,196,955 | $31.0M | 0.70% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,188,060 | $30.8M | 0.01% | −237,725−16.7% | Reduced |
| Affinity Asset Advisors, LLC | 1,011,890 | $26.2M | 1.54% | +22,400+2.3% | Added |
| MPM Oncology Impact Management LP | 1,000,682 | $25.9M | 2.00% | +1,000,682 | New |
| Adage Capital Partners GP, L.L.C. | 950,000 | $24.6M | 0.04% | +616,667+185.0% | Added |
| Vanguard Capital Management LLC | 531,692 | $13.8M | 0.00% | +531,692 | New |
| Morgan Stanley | 500,298 | $13.0M | 0.00% | +429,767+609.3% | Added |
| Cable Car Capital LLC | 400,000 | $10.4M | 3.58% | 00.0% | Unchanged |
| FMR LLC | 340,695 | $8.82M | 0.00% | +29,730+9.6% | Added |
| Millennium Management LLC | 337,983 | $8.75M | 0.01% | +91,298+37.0% | Added |
| Woodline Partners LP | 331,987 | $8.60M | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 233,369 | $6.04M | 0.00% | +233,369 | New |
| AWM Investment Company, Inc. | 200,000 | $5.18M | 0.57% | −36,821−15.5% | Reduced |
| Sphera Funds Management Ltd. | 184,984 | $4.79M | 0.82% | −885−0.5% | Reduced |
| Marshall Wace, LLP | 150,307 | $3.89M | 0.00% | +114,010+314.1% | Added |
| Integral Health Asset Management, LLC | 150,000 | $3.88M | 0.21% | +150,000 | New |
| Susquehanna International Group, LLP | 133,494 | $3.46M | 0.00% | +80,580+152.3% | Added |
| Geode Capital Management, LLC | 125,442 | $3.25M | 0.00% | +833+0.7% | Added |
| Ikarian Capital, LLC | 118,972 | $3.08M | 0.44% | −181,028−60.3% | Reduced |
| Lord, Abbett & Co. LLC | 114,635 | $2.97M | 0.01% | +114,635 | New |
| Ameriprise Financial Inc | 111,788 | $2.90M | 0.00% | −41,239−26.9% | Reduced |
| Russell Investments Group, Ltd. | 91,772 | $2.38M | 0.00% | +91,772 | New |
| Qube Research & Technologies Ltd | 85,969 | $2.23M | 0.00% | +53,782+167.1% | Added |
| Candriam Luxembourg S.C.A. | 84,803 | $2.20M | 0.01% | +84,803 | New |
| Trexquant Investment LP | 73,651 | $1.91M | 0.01% | +60,735+470.2% | Added |
| Vanguard Fiduciary Trust Co | 72,095 | $1.87M | 0.00% | +72,095 | New |
| BlackRock, Inc. | 65,921 | $1.71M | 0.00% | +1,425+2.2% | Added |
| StemPoint Capital LP | 58,020 | $1.50M | 0.29% | +58,020 | New |
| Jane Street Group, LLC | 57,933 | $1.50M | 0.00% | +49,589+594.3% | Added |
| State Street Corp | 54,821 | $1.42M | 0.00% | +4,100+8.1% | Added |
| J. Goldman & Co LP | 54,174 | $1.40M | 0.06% | −6,626−10.9% | Reduced |
| Goldman Sachs Group Inc | 53,473 | $1.38M | 0.00% | −14,550−21.4% | Reduced |
| Wellington Management Group LLP | 29,491 | $763.8K | 0.00% | +29,491 | New |
| Envestnet Asset Management Inc | 28,697 | $743.3K | 0.00% | +9,199+47.2% | Added |
| Mangrove Partners | 25,706 | $665.8K | 0.05% | +25,706 | New |
| Weil Company, Inc. | 24,765 | $641.4K | 0.14% | +24,765 | New |
| Northern Trust Corp | 23,712 | $614.1K | 0.00% | −1,729−6.8% | Reduced |
| Bank of America Corp | 21,606 | $559.6K | 0.00% | +17,634+444.0% | Added |
| Squarepoint Ops LLC | 20,755 | $537.6K | 0.00% | +20,755 | New |
| UBS Group AG | 20,450 | $529.7K | 0.00% | −4,374−17.6% | Reduced |
| 683 Capital Management, LLC | 20,000 | $518.0K | 0.05% | −20,000−50.0% | Reduced |
| Hudson Bay Capital Management LP | 19,083 | $494.3K | 0.00% | +2,541+15.4% | Added |
| Balyasny Asset Management LLC | 18,717 | $484.8K | 0.00% | +18,717 | New |
| Quadrature Capital Ltd | 18,622 | $482.3K | 0.01% | +1,049+6.0% | Added |
| Engineers Gate Manager LP | 16,427 | $425.5K | 0.01% | +16,427 | New |
| Jain Global LLC | 15,597 | $404.0K | 0.01% | −186,836−92.3% | Reduced |
| Two Sigma Investments, LP | 15,509 | $401.7K | 0.00% | −16,299−51.2% | Reduced |
| Brevan Howard Capital Management LP | 14,020 | $363.1K | 0.00% | +14,020 | New |
| ExodusPoint Capital Management, LP | 13,747 | $356.0K | 0.00% | +2,663+24.0% | Added |
| Royal Bank of Canada | 13,389 | $346.0K | 0.00% | +1,403+11.7% | Added |
| Barclays PLC | 13,268 | $343.6K | 0.00% | −10,843−45.0% | Reduced |
| American Century Companies Inc | 12,699 | $328.9K | 0.00% | +4,614+57.1% | Added |
| Alps Advisors Inc | 10,200 | $264.2K | 0.00% | −89−0.9% | Reduced |
| Persistent Asset Partners Ltd | 6,744 | $174.7K | 0.07% | −3,402−33.5% | Reduced |
| Vanguard Global Advisers, LLC | 4,500 | $116.5K | 0.00% | +4,500 | New |
| BNP Paribas Arbitrage, SA | 3,436 | $89.0K | 0.00% | −12,036−77.8% | Reduced |
| Simplex Trading, LLC | 2,312 | $59.9K | 0.00% | −3,703−61.6% | Reduced |
| Wells Fargo & Company | 502 | $13.0K | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 496 | $12.8K | 0.00% | +496 | New |
| Steward Partners Investment Advisory, LLC | 493 | $12.8K | 0.00% | −60−10.8% | Reduced |
| National Bank of Canada | 478 | $12.4K | 0.00% | +402+528.9% | Added |
| Group One Trading, L.P. | 204 | $5.28K | 0.00% | 00.0% | Unchanged |
| Assetmark, Inc | 46 | $1.19K | 0.00% | −12−20.7% | Reduced |
| SBI Securities Co., Ltd. | 12 | $311 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 8 | $211 | 0.00% | +8 | New |
| REAP Financial Group, LLC | 3 | $78 | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −487,275−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −18,804−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −15,804−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −15,600−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,279−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −773−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |